Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology-Reference-Cited by-同舟云学术

Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology

Published:2024-06-21 Issue:8 Volume:29 Page:1081-1087
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Hirose Takeshi,Ito Mamoru,Tsuchihashi Kenji,Ozaki Yukinori,Nishio Hiroshi,Ichihara Eiki,Miura Yuji,Yano Shingo,Maruyama Dai,Yoshinami Tetsuhiro,Susumu Nobuyuki,Takekuma Munetaka,Motohashi Takashi,Baba Eishi,Ochi Nobuaki,Kubo Toshio,Uchino Keita,Kimura Takahiro,Kamiyama Yutaro,Nakao Shinji,Tamura Shinobu,Nishimoto Hitomi,Kato Yasuhisa,Sato Atsushi,Takano Toshimi,Endo Makoto

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10147-024-02572-6.pdf

Reference20 articles.

1. Ogura K, Higashi T, Kawai A (2017) Statistics of bone sarcoma in Japan: report from the bone and soft tissue tumor registry in Japan. J Orthop Sci 22(1):133–143

2. Widhe B, Widhe T (2000) Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint Surg Am 82(5):667–674

3. Sankar S, Lessnick SL (2011) Promiscuous partnerships in Ewing’s sarcoma. Cancer Genet 204(7):351–365

4. Bacci G, Ferrari S, Longhi A et al (2004) Role of surgery in local treatment of Ewing’s sarcoma of the extremities in patients undergoing adjuvant and neoadjuvant chemotherapy. Oncol Rep 11(1):111–120

5. Indelicato DJ, Keole SR, Shahlaee AH et al (2008) Long-term clinical and functional outcomes after treatment for localized Ewing’s tumor of the lower extremity. Int J Radiat Oncol Biol Phys 70(2):501–509